|
ATRN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.59389999987836E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39009999999828E-06 |
| Normal-vs-Stage2 |
1.265990E-01 |
| Normal-vs-Stage3 |
3.046500E-02 |
| Normal-vs-Stage4 |
7.440700E-03 |
| Stage1-vs-Stage2 |
6.862400E-01 |
| Stage1-vs-Stage3 |
8.193800E-01 |
| Stage1-vs-Stage4 |
2.326400E-01 |
| Stage2-vs-Stage3 |
8.827000E-01 |
| Stage2-vs-Stage4 |
2.809200E-01 |
| Stage3-vs-Stage4 |
2.761400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.62319999961336E-07 |
| Normal-vs-AfricanAmerican |
6.135200E-03 |
| Normal-vs-Asian |
4.26379999995952E-06 |
| Caucasian-vs-AfricanAmerican |
6.407000E-01 |
| Caucasian-vs-Asian |
4.203900E-02 |
| AfricanAmerican-vs-Asian |
3.220200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.07909952879504E-10 |
| Normal-vs-Female |
5.887600E-01 |
| Male-vs-Female |
1.101810E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.194300E-04 |
| Normal-vs-Extreme_Weight |
1.53479999820405E-08 |
| Normal-vs-Obese |
6.962700E-03 |
| Normal-vs-Extreme_Obese |
8.470300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.918000E-01 |
| Normal_Weight-vs-Obese |
3.618000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.944400E-01 |
| Extreme_Weight-vs-Obese |
8.584400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.510400E-01 |
| Obese-vs-Extreme_Obese |
5.852000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.404300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.539940E-02 |
| Normal-vs-Age(61-80Yrs) |
8.61719995359778E-09 |
| Normal-vs-Age(81-100Yrs) |
1.34480000468784E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.994200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.130000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.315600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.155800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.185400E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.560100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.54469999972207E-07 |
| Normal-VS-Type2 PRCC |
1.4841999995685E-07 |
| Normal-VS-KIRP CIMP |
3.888400E-01 |
| Normal-VS-Unclassified PRCC |
5.673400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.313040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.165000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.481770E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.596420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.896400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.901200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.70610000000449E-05 |
| Normal-vs-N1 |
3.018200E-03 |
| Normal-vs-N2 |
4.363200E-01 |
| N0-vs-N1 |
6.328000E-01 |
| N0-vs-N2 |
7.378000E-01 |
| N1-vs-N2 |
8.864200E-01 |
|
|
